Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: A comparison

Biochemical and Biophysical Research Communications

Volumn 415, Issue 4, 2011, Pages 579-585

  Vllasaliu, Driton ^a   Fowler, Robyn ^a   Garnett, Martin ^a   Eaton, Mike ^b   Stolnik, Snow ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b VDI   (Germany)

Author keywords

Caco 2; Calu 3; Epithelial barrier; Macromolecular permeability; Mucosal delivery; Tight junctions

Indexed keywords

NANOPARTICLE;

AIRWAY; ARTICLE; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE MUCOSA; MACROMOLECULE; PRIORITY JOURNAL; TIGHT JUNCTION;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL MEMBRANE PERMEABILITY; HUMANS; INTESTINAL MUCOSA; MACROMOLECULAR SUBSTANCES; MODELS, BIOLOGICAL; MUCUS; NANOPARTICLES; RESPIRATORY MUCOSA;

EID: 84855870732     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.108     Document Type: Article

References (32)

1. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175:880-885.
2. Amoako-Tuffour M., Yeung P.K., Agu R.U. Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells. Acta Pharm. 2009, 59:395-405.
3. Li L., Mathias N.R., Heran C.L., Moench P., Wall D.A., Smith R.L. Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers. J. Pharm. Sci. 2006, 95:326-335.
4. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Deliv. Rev. 2006, 58:1030-1060.
5. Grainger C.I., Greenwell L.L., Lockley D.J., Martin G.P., Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm. Res. 2006, 23:1482-1490.
6. Bock. Validation of the Caco-2 cell monolayer system for determining the permeability of drug substances according to the Biopharmaceutics Classification System (BCS). <>. http://www.acrossbarriers.de.
7. Smith P.L., Yeulet S.E., Citerone D.R., Drake F., Cook M., Wall D.A., Marcello J. SK & F 110679: comparison of absorption following oral or respiratory administration. J. Controlled Release 1994, 28:67-77.
8. L. de Vries, C.E. Reitzema-Klein, A. Meter-Arkema, A. van Dam, R. Rink, G.N. Moll, M.H. Akanbi, Oral and pulmonary delivery of thioether-bridged angiotensin-(1-7), Peptides 31 893-8.
9. Kamath A.V., Morrison R.A., Mathias N.R., Dando S.A., Marino A.M., Chong S. Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells. Arch. Pharm. Res. 2007, 30:1002-1007.
10. Florea B.I., Cassara M.L., Junginger H.E., Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J. Controlled Release 2003, 87:131-138.
11. Matsukawa Y., Lee V.H., Crandall E.D., Kim K.J. Size-dependent dextran transport across rat alveolar epithelial cell monolayers. J. Pharm. Sci. 1997, 86:305-309.
12. Yu C.M., Mun S., Wang N.H. Phenomena of insulin peak fronting in size exclusion chromatography and strategies to reduce fronting. J. Chromatogr. A 2008, 1192:121-129.
13. Simister N.E., Rees A.R. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur. J. Immunol. 1985, 15:733-738.
14. Simister N.E., Mostov K.E. An Fc receptor structurally related to MHC class I antigens. Nature 1989, 337:184-187.
15. Spiekermann G.M., Finn P.W., Ward E.S., Dumont J., Dickinson B.L., Blumberg R.S., Lencer W.I. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 2002, 196:303-310.
16. Claypool S.M., Dickinson B.L., Wagner J.S., Johansen F.E., Venu N., Borawski J.A., Lencer W.I., Blumberg R.S. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol. Biol. Cell 2004, 15:1746-1759.
17. Dickinson B.L., Badizadegan K., Wu Z., Ahouse J.C., Zhu X., Simister N.E., Blumberg R.S., Lencer W.I. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J. Clin. Invest. 1999, 104:903-911.
18. Sato K., Nagai J., Mitsui N., Ryoko Y., Takano M. Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells. Life Sci. 2009, 85:800-807.
19. C.W. Davis, S.H. Randell, Airway goblet and mucous cells: identical, similar, or different? in: S.M. (Ed.), Cilia and Mucus: from Development to Respiratory Defense, Marcel Dekker, pp. 195-210.
20. Shen B.Q., Finkbeiner W.E., Wine J.J., Mrsny R.J., Widdicombe J.H. Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl-secretion. Am. J. Physiol. 1994, 266:L493-L501.
21. Kreda S.M., Okada S.F., van Heusden C.A., O'Neal W., Gabriel S., Abdullah L., Davis C.W., Boucher R.C., Lazarowski E.R. Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells. J. Physiol. 2007, 584:245-259.
22. Man A.L., Lodi F., Bertelli E., Regoli M., Pin C., Mulholland F., Satoskar A.R., Taussig M.J., Nicoletti C. Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. J. Immunol. 2008, 181:5673-5680.
23. Lindmark T., Kimura Y., Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharmacol. Exp. Ther. 1998, 284:362-369.
24. Dickman K.G., Hempson S.J., Anderson J., Lippe S., Zhao L., Burakoff R., Shaw R.D. Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G757-G766.
25. Jauhari S., Dash A.K. A mucoadhesive in situ gel delivery system for paclitaxel. AAPS Pharm. Sci. Tech. 2006, 7:E53.
26. Sun F., Tai S., Lim T., Baumann U., King M. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum. Can. Respir. J. 2002, 9:401-406.
27. Carino G.P., Jacob J.S., Mathiowitz E. Nanosphere based oral insulin delivery. J. Controlled Release 2000, 65:261-269.
28. Jani P., Halbert G.W., Langridge J., Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 1989, 41:809-812.
29. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 2000, 50:147-160.
30. Vila A., Sanchez A., Tobio M., Calvo P., Alonso M.J. Design of biodegradable particles for protein delivery. J. Controlled Release 2002, 78:15-24.
31. Brooking J., Davis S.S., Illum L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target. 2001, 9:267-279.
32. de la Fuente M., Csaba N., Garcia-Fuentes M., Alonso M.J. Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomedicine (Lond.) 2008, 3:845-857.